|
|
|
Company
Name |
Short
Summary |
| Allon
Therapeutics |
Allon
Therapeutics is involved in the discovery, development
and commercialization of drugs to treat neurodegenerative
diseases that lead to memory loss and cognitive
impairment. |
| Angiotech
Pharmaceuticals |
Angiotech
pharmaceuticals is involved in the development and
comercialization of drug-eluting medical devices
and biomaterials. |
| Apotex |
Apotex produces more than 300 generic pharmaceuticals in approximately 4,000 dosages and formats. |
| BRI Biopharmaceucal Research |
BRI Biopharmaceutical Research is a contract research organization (CRO) focused on providing discovery, preclinical and clinical program support for pharmaceutical and biotechnology companies. |
| Cardiome
Pharma |
Cardiome
Pharma is involved in the development and comercialization
of drugs for the treatment of atrial arrhythmias
and congestive heart failure. |
| Celator Pharmaceuticals |
Celator Pharmaceuticals is focused on the development of synergistic ratios of drugs to improve therapies to treat cancer. |
| DelMar Pharmaceuticals |
DelMar Pharmaceuticals is focused on the development and commercialization of small molecule anti-cancer therapies in new cancer indications. |
| iCo Therapeutics |
iCo Therapeutics is focused on the development of reformulated drugs with clinical history for new or expanded indications. |
| Med BioGene |
Med BioGene is focused on the development and commercialization of genomic-based clinical laboratory diagnostic tests. |
| Ondine Biomedical |
Ondine Biomedical is focused on the development and commercialization of photodisinection for the treatment of bacterial, viral and fungal infections. |
| OncoGenex Pharmaceuticals |
OncoGenex Pharmaceuticals is focused on the research and development of cancer therapeutics. |
| Protox Therapeutics |
Protox Therapeutics is focused on the development of altered naturally occurring proteins for the treatment of prostate diseases and various cancers. |
| QLT |
QLT is focused on the research, development, and commercialization of therapeutics for ocular diseases. |
| Qu Biologics |
Qu Biologics is focused on the research and development of site specific immunomodulators (SSIs) to treat patients with inflammatory disorders and cancer. |
| Sirius Genomics |
Sirius Genomics is focused on the development and commercialization of DNA-based diagnostics and pharmacogenetic tests. |
| Sirona Biochem |
Sirona Biochem is focused on the research and development of therapeutics, cosmeceuticals, and biological ingredients using techniques to improve the pharmaceutical qualities of carbohydrate-based molecules. |
| Zalicus |
Zalicus is focused on the research, development, and commercialization of treatments for pain and inflammatory diseases. |
